High prevalence of primary multidrug resistant tuberculosis in persons with no known risk factors

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Otero, Larissa ^a   Krapp, Fiorella ^a   Tomatis, Cristina ^a   Zamudio, Carlos ^a   Matthys, Francine ^b   Gotuzzo, Eduardo ^a   van der Stuyft, Patrick ^b   Seas, Carlos ^a  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADULT; ALCOHOL ABUSE; ANTIBIOTIC RESISTANCE; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PERU; PREVALENCE; PRISONER; RISK FACTOR; SPUTUM CULTURE; STRUCTURED QUESTIONNAIRE; ENDEMIC DISEASE; MASS SCREENING; METHODOLOGY;

ENDEMIC DISEASES; HUMANS; MASS SCREENING; PERU; PREVALENCE; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 80055050542     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026276     Document Type: Article

References (21)

1. World Health Organization (WHO) (2010) World Health Organization Global Report 2009. Available: http://www.who.int/tb/publications/global_report/en/ Accessed 2011 Jan 12.
2. Ridderhof JC, Van Deun A, Kam KM, Narayanan PR, Aziz MA, (2007) Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ 85 (5): 354-359.
3. WHO (2008) Guidelines for the programmatic management of drug-resistant tuberculosis WHO/HTM/TB/2008.402. Available: http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf. Accessed 2011 Jan 4.
4. Caminero JA, (2010) Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis 14 (4): 382-390.
5. WHO (2008) The WHO/IUATLD Global project of anti-tuberculosis drug resistance surveillance.Anti-tuberculosis Drug Resistance in the World. Report N°4. WHO/HTM/TB/2008.394. Available: http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf. Accessed 2011 Jan 4.
6. Asencios L, Quispe N, Mendoza-Ticona A, Leo E, Vásquez I, et al. (2009) Vigilancia Nacional de la Resistencia a Medicamentos Antituberculosos, Perœ 2005-2006. Rev Peru Med Exp Salud Publica 26 (3): 278-287.
7. Bonilla C, (2008) Situación de la tuberculosis en el Perú. Acta Med Per 25 (3): 163-170.
8. Ministerio de Salud (2006) Estrategia Sanitaria Nacional para la Prevención y Control de la Tuberculosis. Norma Técnica de Salud para el Control de la Tuberculosis. Available: ftp://ftp2.minsa.gob.pe/descargas/dgsp/ESN-tuberculosis/normaspublicaciones/NTSTBC.pdf. Accessed: 2011 Jan 20.
9. Velásquez GE, Yagui M, Cegielski P, Asencios L, Bayona J, et al. (2011) Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005-2008. Emerg Infect Dis 17 (3): 432-440.
10. Ministerio de Salud (2010) Estadísticas Población. Available: http://www.minsa.gob.pe/estadisticas/estadisticas/Poblacion/PoblacionMarcos.asp?15. Accessed 2011 Jan 20.
11. Ministerio de Salud (2005) Dirección de Salud IV Lima Este. Análisis de la situación de salud 2005 de la Dirección de Salud IV Lima Este Lima, Peru Dirección de Salud IV Lima Este Available: http://www.limaeste.gob.pe/Estadistica/IframeEstadistica.asp. Accessed 2011 Jan 20.
12. Ministerio de Salud (2010) Dirección de Salud IV Lima Este. Plan Operativo Institucional Ejercicio Fiscal 2010. Available: http://www.peru.gob.pe/docs/PLANES/13296/PLAN_13296_POI_2010.pdf. Accessed 2011 Jan 20.
13. Ministerio de Salud (2006) Estrategia Sanitaria Nacional para la Prevención y Control de la Tuberculosis. Construyendo alianzas estratégicas para detener la tuberculosis: la experiencia peruana. Available: ftp://ftp2.minsa.gob.pe/descargas/dgsp/ESN-tuberculosis/normaspublicaciones/ConstruyendoAlianzasEstrategicas.pdf. Accessed 2011 Feb 3.
14. Ministerio de Salud (2010) Estrategia Sanitaria Nacional para la Prevención y Control de la Tuberculosis. Informe Operacional 2010. Available: www.minsa.gob.pe. Accessed 2011 Sep 30.
15. Toman K, (2004) What is the probability of obtaining a negative culture from a sputum specimen found positive by smear microscopy? In: Frieden T, editors. Toman. Second edition edition Geneva World Health Organization WHO/HTM/TB/2004.334; 2004 pp. 44-45.
16. Caminero JA, (2008) Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation. Int J Tuberc Lung Dis 12 (8): 869-877.
17. Suchindran S, Brouwer ES, Van Rie A, (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One 4 (5): e5561.
18. Lomtadze N, Aspindzelashvili R, Janjgava M, Mirtskhulava V, Wright A, et al. (2009) Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study. Int J Tuberc Lung Dis 13 (1): 68-73.
19. Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, et al. (2010) Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 5 (11).
20. Temple B, Ayakaka I, Ogwang S, Nabanjja H, Kayes S, et al. (2009) Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis 47 (9): 1126-1134.
21. Barroso EC, Salani RM, Oliveira R, Oliveira AL, Brasileiro B, et al. (2003) Risk factors for acquired multidrug-resistant tuberculosis. J Pneumologia 29 (2).